| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/18/2009 | EP2035022A1 Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin |
| 03/18/2009 | EP2035009A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 03/18/2009 | EP2034999A2 Dha esters and use thereof in treatment and prevention of cardiovascular disease |
| 03/18/2009 | EP2034989A2 Methods and compositions for improving cognitive function |
| 03/18/2009 | EP2034966A1 A stabilised composition comprising ace inhibitors |
| 03/18/2009 | EP2034830A1 Methods of treating stroke |
| 03/18/2009 | EP1641803B1 Thienopyrimidine derivatives as potassium channel inhibitors |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1333816B1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 03/18/2009 | EP1140139B2 Use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389626A Fused ring heterocycle kinase modulators |
| 03/18/2009 | CN101389606A Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) |
| 03/18/2009 | CN101389598A Aliskiren nitrate salt |
| 03/18/2009 | CN101389332A Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke |
| 03/18/2009 | CN101389329A Method for increasing blood and/or promoting organic regeneration |
| 03/18/2009 | CN101389326A Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 03/18/2009 | CN101389321A Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386848A MiRNA with cell corpuscule as vector and preparation research approach thereof and application |
| 03/18/2009 | CN101386634A Hyperin extraction method and preparation and use thereof |
| 03/18/2009 | CN101386612A Compounds with 3-phenyl-7-hydroxyl tonka bean camphor structure and medicinal use thereof |
| 03/18/2009 | CN101386604A Aromatic nitrile-base thiazole derivatives for inhibiting xanthine oxidase activity, preparation method and application |
| 03/18/2009 | CN101386594A 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/18/2009 | CN101385849A Use of human source nitrosylation thioredoxin in preparing medicine for treating ischemic heart disease |
| 03/18/2009 | CN101385846A Preparation method of Jiawei Xiaoyao power preparation |
| 03/18/2009 | CN101385844A Traditional Chinese medicine composition for treating the hemorrhoids and preparation method thereof |
| 03/18/2009 | CN101385819A Medicine for treating the hemorrhoids and preparation method thereof |
| 03/18/2009 | CN101385814A Medicine for treating the coronary heart disease and preparation method thereof |
| 03/18/2009 | CN101385808A Quality control method of Zhubai tranquilizing pill |
| 03/18/2009 | CN101385795A Pure traditional Chinese medicine preparation for treating hypertension and preparation method thereof |
| 03/18/2009 | CN101385793A High-purity extraction method of total flavone from cherokee rose and use thereof in preparing medicine for treating cardio-cerebrovascular disease |
| 03/18/2009 | CN101385792A Liquor for treating disease and preparation method thereof |
| 03/18/2009 | CN101385767A Watermelon seeds oil soft capsules and preparation method thereof |
| 03/18/2009 | CN101385748A Maniod ebish flower extract, extraction and analysis method and extract preparation and use thereof |
| 03/18/2009 | CN101385738A Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 03/18/2009 | CN101385723A Association between an anti-atherothrombotic and an angiotensin conversion enzyme inhibitor |
| 03/18/2009 | CN101385718A Osmotic pump preparation composition for treating hyperlipemia |
| 03/18/2009 | CN101385600A Chinese herbal medicine health-care silk quilt |
| 03/18/2009 | CN100469894C Method for preparing laver blood pressure-reducing peptide by using enzyme-membrane coupling technique and application thereof |
| 03/18/2009 | CN100469878C Vascular adhesion molecules and modulation of their function |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469787C Method for the synthesis of derivatives of (2S,3AS,7AS)-1-[(S)-1-alanyl]-octahydro-1H-indole-2-carboxylic acid and use thereof for the synthesis of perindopril |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469399C Electrothermal cap for dredging cerebral meridian and its making process |
| 03/18/2009 | CN100469372C Xindakang drip pill and preparation thereof |
| 03/18/2009 | CN100469371C Manufacturing technique for gingko leaf extracts |
| 03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/18/2009 | CN100469360C Soft capsule of indapamide |
| 03/18/2009 | CN100469358C Deer heart powder capsule and preparation method thereof |
| 03/18/2009 | CN100469356C Slowly released tablet of compound atenolol, and preparation method |
| 03/18/2009 | CA2639640A1 Local vascular delivery of mtor inhibitors in combination with peroxisome proliferators-activated receptor stimulators |
| 03/17/2009 | US7504435 Method for stimulating weight loss and/or for lowering triglycerides in patients |
| 03/17/2009 | US7504433 e.g. (2-Methyl-4-{2-[3-methyl-5-(4-trifluoromethyl-phenyl)-thiophen-2-yl]-propylsulfanyl}-phenoxy)-acetic acid;peroximose proliferator activated receptor; antidiabetic agent,atherosclerosis |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504417 Substituted benzene derivatives or salts thereof |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504390 Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 03/17/2009 | US7504388 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 03/17/2009 | US7504257 Embryonic stem cells and neural progenitor cells derived therefrom |
| 03/17/2009 | US7504247 2-O sulfatase compositions and methods of degradation therewith |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504226 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504100 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2429263C Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2360668C The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/17/2009 | CA2346863C Therapeutic use of polymers |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2339283C A process for the preparation of zofenopril calcium salt |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 03/12/2009 | WO2009033095A2 Humanized pai-1 antibodies |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009031842A1 Use of trim72 as a target for muscle and heart enhancer |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031575A1 Therapeutic or prophylactic agent for posterior ocular disease comprising lithium salt as active ingredient |
| 03/12/2009 | WO2009030373A1 Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events |
| 03/12/2009 | WO2009029998A1 Retrometabolic compounds |
| 03/12/2009 | WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 03/12/2009 | WO2009009587A3 Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same |
| 03/12/2009 | WO2008137778A3 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
| 03/12/2009 | WO2008124088A3 Compositions and methods for the treatment of heart failure |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | WO2007138621A8 Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin |
| 03/12/2009 | US20090069789 Methods and devices for local therapeutic agent delivery to heart valves |
| 03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |